product summary
company name :
Cell Signaling Technology
product type :
antibody
product name :
RECK (D8C7) Rabbit mAb
catalog :
3433
clonality :
monoclonal
host :
domestic rabbit
conjugate :
nonconjugated
clone name :
D8C7
reactivity :
human, mouse, brown rat
application :
western blot
citations: 5
Published Application/Species/Sample/DilutionReference
  • western blot; mouse; 1:2000; loading ...; fig 4b
Cho C, Wang Y, Smallwood P, Williams J, Nathans J. Molecular determinants in Frizzled, Reck, and Wnt7a for ligand-specific signaling in neurovascular development. elife. 2019;8: pubmed publisher
  • western blot; human; 1:5000; loading ...; fig s9i
Ulrich F, Carretero Ortega J, Menendez J, Narvaez C, Sun B, Lancaster E, et al. Reck enables cerebrovascular development by promoting canonical Wnt signaling. Development. 2016;143:147-59 pubmed publisher
Rabien A, Stephan C, Kilic E, Weichert W, Kristiansen G, Miller K, et al. Renal cell neoplasias: reversion-inducing cysteine-rich protein with Kazal motifs discriminates tumor subtypes, while extracellular matrix metalloproteinase inducer indicates prognosis. J Transl Med. 2013;11:258 pubmed publisher
Hirata H, Ueno K, Shahryari V, Deng G, Tanaka Y, Tabatabai Z, et al. MicroRNA-182-5p promotes cell invasion and proliferation by down regulating FOXF2, RECK and MTSS1 genes in human prostate cancer. PLoS ONE. 2013;8:e55502 pubmed publisher
Hirata H, Ueno K, Shahryari V, Tanaka Y, Tabatabai Z, Hinoda Y, et al. Oncogenic miRNA-182-5p targets Smad4 and RECK in human bladder cancer. PLoS ONE. 2012;7:e51056 pubmed publisher
product information
SKU :
3433S
Product-Name :
RECK (D8C7) Rabbit mAb
Size :
100 ul
Price-(USD) :
235 USD
Species-x-Reactivity :
H, M, R, Mk
Applications :
Western blot
Product-Category :
Adhesion/ECM
Shipping-Temp :
AMBIENT
Storage-Temp :
-20°C
Product-Type :
Monoclonal Antibody
MW :
110
Host :
Rabbit
Target :
RECK
Primary-Protein :
RECK
Alt-Names :
RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,ST15,Suppressor of tumorigenicity 15 protein,hRECK,membrane-anchored glycoprotein (metastasis and invasion),reversion-inducing-cysteine-rich protein with kazal motifs,suppression of tumorigenicity 15 (reversion-inducing-cysteine-rich protein with kazal motifs),suppression of tumorigenicity 5 (reversion-inducing-cysteine-rich protein with kazal motifs)
company information
Cell Signaling Technology
3 Trask Lane
Danvers, MA 01923
info@cellsignal.com
https://www.cellsignal.com
8776162355
headquarters: USA
Established in Beverly, MA in 1999, Cell Signaling Technology (CST) is a privately-owned company with over 400 employees worldwide. We are dedicated to providing innovative research tools that are used to help define mechanisms underlying cell function and disease. Since its inception, CST has become the world leader in the production of the highest quality activation-state and total protein antibodies utilized to expand knowledge of cell signaling pathways. Our mission is to deliver the world's highest quality research tools that accelerate progress in biological research and personalized medicine.